Latterell Venture Partners logo

Latterell Venture Partners

North America, California, United States, San Francisco

Description

Latterell Venture Partners is a venture capital firm specializing in startups and early stage healthcare companies.

Investor Profile

Latterell Venture Partners has made 55 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series B (35%)
  • Series C (24%)
  • Series A (22%)
  • Series Unknown (11%)
  • Series F (2%)
  • Private Equity (2%)
  • Series E (2%)
  • Series G (2%)
  • Series D (2%)

Country Focus

  • United States (98%)
  • South Korea (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Life Science
  • Manufacturing
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Latterell Venture Partners frequently co-invest with?

DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 12
Domain Associates
North America, California, United States, San Diego
Co-Investments: 5
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 7
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 10
Split Rock Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 5
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 6
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 14
P
North America, Illinois, United States, Northbrook
Co-Investments: 5
The Vertical Group
North America, New Jersey, United States, Basking Ridge
Co-Investments: 15
HLM Venture Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6

Which angels does Latterell Venture Partners often collaborate with?

GM
North America, Texas, United States, Houston
Shared Deals: 1
AP
North America, New Jersey, United States, Hackensack
Shared Deals: 1

What are some of recent deals done by Latterell Venture Partners?

Viracta Therapeutics

Cardiff By The Sea, California, United States

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series ENov 30, 2020
Amount Raised: $40,000,000
Pulmonx

Redwood City, California, United States

Pulmonx provides minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

Health CareMedical Device
Series GMay 9, 2019
Amount Raised: $65,000,000
Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series BDec 18, 2017
Amount Raised: $70,000,000
Viracta Therapeutics

Cardiff By The Sea, California, United States

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series BApr 4, 2017
Amount Raised: $18,400,000
Neuraltus Pharmaceuticals

Palo Alto, California, United States

Neuraltus Pharmaceuticals is focused on developing therapeutics that meet critical unmet needs in treating neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
Series UnknownMay 24, 2016
Amount Raised: $14,938,357
Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series AMay 10, 2016
Amount Raised: $65,000,000
PerceptiMed

Mountain View, California, United States

PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.

BiotechnologyHealth CareMedicalMedical Device
Series AMar 27, 2015
Amount Raised: $5,352,237
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000
Transcend Medical

Menlo Park, California, United States

Transcend Medical focuses on the research and development of novel devices for the treatment of glaucoma.

Health CareMedicalMedical Device
Series CApr 2, 2014
Amount Raised: $29,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series BDec 17, 2012
Amount Raised: $38,000,000